AI assistant
INSMED Inc — Director's Dealing 2024
Jun 5, 2024
30150_dirs_2024-06-05_7ea126bf-f112-4c4e-9775-9ccb5f246907.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-06-03
Reporting Person: Schaeffer Orlov S Nicole (Chief People Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-03 | Common Stock | M | 13750 | $16.07 | Acquired | 122510 | Direct |
| 2024-06-03 | Common Stock | M | 41250 | $22.76 | Acquired | 163760 | Direct |
| 2024-06-03 | Common Stock | S | 55000 | $55.33 | Disposed | 108760 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-03 | Stock Option (right to buy) | $16.07 | M | 13750 | Disposed | 2025-01-08 | Common Stock (13750) | Direct |
| 2024-06-03 | Stock Option (right to buy) | $22.76 | M | 41250 | Disposed | 2025-05-21 | Common Stock (41250) | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 55,000 shares sold at prices ranging from $54.69 to $55.65 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.